BioNano Genomics, Inc. (BNGO)

NASDAQ: BNGO · IEX Real-Time Price · USD
2.15
-0.14 (-6.11%)
At close: Jan 21, 2022 4:00 PM
2.13
-0.02 (-0.93%)
After-hours:Jan 21, 2022 7:59 PM EST
Market Cap621.75M
Revenue (ttm)15.67M
Net Income (ttm)-61.22M
Shares Out289.18M
EPS (ttm)-0.25
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,502,242
Open2.25
Previous Close2.29
Day's Range2.11 - 2.30
52-Week Range2.11 - 15.69
Beta1.75
AnalystsBuy
Price Target12.00 (+458.1%)
Earnings Daten/a

About BNGO

Bionano Genomics, Inc., a genome analysis company, provides tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing. Its Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables scientists and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. The company also provides diagnostic testing for those with autism spectrum disorde...

IndustryLife Sciences Tools & Services
IPO DateAug 21, 2018
CEOR. Erik Holmlin
Employees147
Stock ExchangeNASDAQ
Ticker SymbolBNGO
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for BNGO stock is "Buy." The 12-month stock price forecast is 12.00, which is an increase of 458.14% from the latest price.

Price Target
$12.00
(458.14% upside)
Analyst Consensus: Buy

News

UPDATE -- Bionano Genomics Announces its Support for the ACMG Foundation for Genetic and Genomic Medicine and its Nex...

SAN DIEGO, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software solu...

3 days ago - GlobeNewsWire

Bionano Genomics Announces its Support for the AGMG Foundation for Genetic and Genomic Medicine and its Next Generati...

SAN DIEGO, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software solu...

4 days ago - GlobeNewsWire

Bionano Genomics Hosts Final Day of 2022 Symposium with Presentations Demonstrating the Combined Detection Power of O...

SAN DIEGO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software solu...

1 week ago - GlobeNewsWire

Bionano Genomics Hosts Day 3 of 2022 Symposium with New Research Demonstrating Applications of OGM in Solid Tumor Ana...

SAN DIEGO, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software solu...

1 week ago - GlobeNewsWire

Bionano Genomics Preliminary Q4, FY21 Revenue Exceed Expectations

Bionano Genomics Inc (NASDAQ: BNGO) posted preliminary Q4 sales of $5.8 million - $6.2 million, +25% - 33% sequentially, up 45% - 55% Y/Y, and above the consensus of $5.44 million. FY21 revenue is expec...

1 week ago - Benzinga

Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2021 Results

- Preliminary Q4 revenue expected between $5.8 and $6.2 million; 45%-55% increase over Q4 2020

1 week ago - GlobeNewsWire

Bionano Genomics Hosts Day 2 of 2022 Symposium with New Research Demonstrating How OGM Detects Known and Novel Varian...

SAN DIEGO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software solu...

1 week ago - GlobeNewsWire

UPDATE - Bionano Genomics Hosts Day 1 of 2022 Symposium with Six Presentations Highlighting the Superior Performance ...

SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software solu...

1 week ago - GlobeNewsWire

Bionano Genomics Hosts Day 1 of 2022 Symposium with Six Presentations Highlighting the Superior Performance of OGM in...

SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading software solu...

1 week ago - GlobeNewsWire

7 of the Best Cheap Stocks Under $10 for 2022 to Buy Now

These cheap stocks under $10 are poised to rally in the new, more friendly macro environment that's in place as 2022 unfolds. The post 7 of the Best Cheap Stocks Under $10 for 2022 to Buy Now appeared f...

Other symbols:AYROICADQUBTSFETSOLO
2 weeks ago - InvestorPlace

Bionano Genomics Stock Is a Low-Priced Bet on Sound Science

Even though BNGO stock investors struggled in 2021, prepare for new price discovery as Bionano pushes the envelope in optical genome mapping. The post Bionano Genomics Stock Is a Low-Priced Bet on Sound...

2 weeks ago - InvestorPlace

Best Penny Stocks to Buy in January 2022? 3 to Watch Next Week

Add these penny stocks to your January 2022 watchlist The post Best Penny Stocks to Buy in January 2022? 3 to Watch Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt...

Other symbols:CBATCTRM
3 weeks ago - PennyStocks

Bionano Announces Prototype for its Next Single Molecule Imaging System for OGM

SAN DIEGO, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of the leading software solutions for vis...

3 weeks ago - GlobeNewsWire

The Critics Are Wrong About Bionano Stock

The critics of Bionano are greatly underestimating the vast potential of Saphyr and of BNGO stock for long-term investors. The post The Critics Are Wrong About Bionano Stock appeared first on InvestorPl...

3 weeks ago - InvestorPlace

University Hospitals Leuven in Belgium Outlines their Menu Expansion Plans for Optical Genome Mapping as One of their...

SAN DIEGO, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of the leading software solutions for vis...

1 month ago - GlobeNewsWire

Bionano Genomics Appoints Vince Wong to its Board of Directors

SAN DIEGO, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of the leading software solutions for vis...

1 month ago - GlobeNewsWire

This Analyst's Saphyr Calculations Suggest Buying Bionano While It's Down

If BNGO stock reaches Oppenheimer's price target, investors are looking at a return of more than 300%, plus long-term growth potential. The post This Analyst's Saphyr Calculations Suggest Buying Bionano...

1 month ago - InvestorPlace

Do Options Traders Know Something About Bionano (BNGO) Stock We Don't?

Investors need to pay close attention to Bionano (BNGO) stock based on the movements in the options market lately.

1 month ago - Zacks Investment Research

Bionano Genomics Proves Not Everything Genetic is Gold

Bionano sells a $150,000 machine called Saphyr that does genetic mapping. It's a solid device, but its future remains in the future, as do BNGO stock fortunes.

1 month ago - InvestorPlace

3 Incredibly Cheap Growth Stocks That Could Make You a Millionaire

Bionano Genomics, BioCryst Pharmaceuticals, and NRx Pharmaceuticals all have the potential to make their early shareholders rich.

Other symbols:BCRXNRXP
1 month ago - The Motley Fool

Wait for Bionano Stock to Fall Further Before Buying

BNGO stock is breaking down following the latest earnings report, and there are no major catalysts to push shares up in the short term. The post Wait for Bionano Stock to Fall Further Before Buying appe...

2 months ago - InvestorPlace

Bionano's Is on Track for Growth Thanks to Saphyr

BNGO stock beats analyst forecasts yet again. Flush with cash and with Saphyr installations rising, this stock remains a high potential play.

2 months ago - InvestorPlace

With Progress on Multiple Fronts, Bionano Genomics Stock Is Great Buy Here

Bionano's acquisition of a software company makes Saphyr more attractive, and studies should result in insurers reimbursing those who use the system. BNGO stock is a buy.

2 months ago - InvestorPlace

Bionano Genomics, Inc. (BNGO) Reports Q3 Loss, Tops Revenue Estimates

Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -16.67% and 16.38%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Bionano Genomics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that, in accordance with Nasdaq Listing Rule 5635(c)(4), the Compensation Committee of its Board of Dir...

2 months ago - GlobeNewsWire